Add to Quick Collection All 13 Results
Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines
Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
Heterocyclic substituted cantharidin and norcantharidin analogues-synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity
Nab-paclitaxel: a bright new SPARC in taxane therapy of cancer (editorial)
Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition
Norcantharimides, synthesis and anticancer activity: synthesis of new norcantharidin analogues and their anticancer evaluation
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer
Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect
Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition
A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients
Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity
Yeong, Tuck Wai 2009
Copyright © 2007 | The University of Newcastle, Australia | CRICOS Provider Number 00109J